Ipamorelin dose guide

Ipamorelin dosage

Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides. Commonly reported: deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.

Dose range

200–300 mcg (research range). Studied in research — not a recommendation.

How often

2–3× daily: 2–3x daily, best fasted or before bed

A typical run

8–16 weeks. Commonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.

How it’s taken

Vial: SubQ injection, IM injection

Evidence

Moderate: Animal studies + some human data

Half-life

~2 hours (measured in healthy men, given IV)

Ipamorelin on your syringe

With a 5 mg vial and 2 mL of water (2.5 mg in every mL), on a 0.3 mL (30-unit) U-100 insulin syringe: the low end, 200 mcg, is 8 units; and the high end, 300 mcg, is 12 units. 25 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.

What to take alongside each peptideIpamorelin in the peptide libraryThe Dose Guide: every peptide

More growth hormone peptides

• CJC-1295 with DAC 1–2 mg
• CJC-1295 no DAC 100–200 mcg
• Sermorelin 200–500 mcg
• Tesamorelin 1–2 mg
• GHRP-2 100–300 mcg
• GHRP-6 100–300 mcg
• Hexarelin 100–200 mcg
• MK-677 10–25 mg
• Fragment 176-191 250–500 mcg
• IGF-1 LR3 20–50 mcg
• PEG-MGF 200–400 mcg
• Follistatin-344 100–200 mcg
• HGH 1–4 IU

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.